The Association of Age-related Maculopathy Susceptibility 2 (ARMS2) and Complement Factor H (CFH) Variants with Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

References

• Cook HL, Patel PJ, Tufail A. Age-related macular degeneration: diagnosis and management. Br Med Bull 2008;85:127–149
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007;144:15–22
   PubMed Web of Science ®Google Scholar
• Liu Y, Wen F, Huang S, et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007;245:1441–1445
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10:1–8
   PubMed Web of Science ®Google Scholar
• Bessho H, Honda S, Imai H, et al. Natural course and funduscopic findings of polypoidal choroidal vasculopathy in a Japanese population over one year of follow-up. Retina 2011;31:1598–1602
   Google Scholar
• Uyama M, Wada M, Nagai Y, et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 2002;133:639–648
   PubMed Web of Science ®Google Scholar
• Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121:1392–1396
   PubMedGoogle Scholar
• Honda S, Kurimoto Y, Kagotani Y, et al. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, Japan. Jpn J Ophthalmol 2009;53:593–597
   Google Scholar
• Honda S, Imai H, Yamashiro K, et al. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan. Ophthalmologica 2009;223:333–538
   Google Scholar
• Byeon SH, Lew YJ, Lee SC, et al. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Acta Ophthalmol 2010;88:660–668
   Google Scholar
• Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 2010;24:483–490
   Google Scholar
• Tanaka K, Nakayama T, Mori R, et al. Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2011;52:7441–7444
   Google Scholar
• Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy [in Japanese]. Nippon Ganka Gakkai Zasshi 2005;109:417–427
   PubMedGoogle Scholar
• Solé X, Guino E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22:1928–1929
   PubMed Web of Science ®Google Scholar
• Yanagisawa S, Kondo N, Miki A, et al. Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2). Mol Vis 2011;17:3574–3582
   Web of Science ®Google Scholar
• Gotoh N, Yamada R, Nakanishi H, et al. Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin Experiment Ophthalmol 2008;36:437–442
   PubMedGoogle Scholar
• Hayashi H, Yamashiro K, Gotoh N, et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 2010;51:5914–5919
   PubMed Web of Science ®Google Scholar
• Sakurada Y, Kubota T, Imasawa M, et al. Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy. Retina 2009;29:1522–1526
   PubMed Web of Science ®Google Scholar
• Sakurada Y, Kubota T, Imasawa M, et al. Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 2010;30:1616–1621
   PubMed Web of Science ®Google Scholar
• Tsuchihashi T, Mori K, Horie-Inoue K, et al. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration. Ophthalmology 2011;118:93–100
   PubMed Web of Science ®Google Scholar
• Tsujikawa A, Ojima Y, Yamashiro K, et al. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am J Ophthalmol 2011;151:961–972
   Google Scholar
• Bessho H, Honda S, Kondo N, et al. The association of ARMS2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis 2011;17:977–982
   PubMed Web of Science ®Google Scholar
• Lee WK, Kim KS, Kim W, et al. Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters. Am J Ophthalmol 2012;154:355–365
   Google Scholar
• Koh A, Lee WK, Chen LJ, et al. The Everest Study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012;32:1453–1464
   PubMed Web of Science ®Google Scholar
• Nakashizuka H, Mitsumata M, Okisaka S, et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008;49:4729–4737
   Google Scholar
• Kondo N, Bessho H, Honda S, et al. Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2011;118:339–344
   PubMed Web of Science ®Google Scholar